Correction to Pharmacokinetics and pharmacodynamics of itepekimab in adults with moderate-to-severe atopic dermatitis: Results from two terminated phase II trials

IF 3.1 3区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Cts-Clinical and Translational Science Pub Date : 2024-09-19 DOI:10.1111/cts.70026

引用次数: 0

Abstract

Concentration time proles of total IL-33 in East Asian and non-East Asian patients during the study period in the (A) dose-ranging study and (B) proof-of-concept study.

In Figure S4 (all panels), the Y-axis label should be ng/mL, not mg/L.

We apologize for this error.

Abstract Image

查看原文本刊更多论文

更正 "伊替匹单抗在中重度特应性皮炎成人患者中的药代动力学和药效学"：两项终止的II期试验结果

在(A)剂量范围研究和(B)概念验证研究中，东亚和非东亚患者在研究期间总 IL-33 的浓度时间曲线。在图 S4（所有面板）中，Y 轴标签应为 ng/mL，而不是 mg/L。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cts-Clinical and Translational Science 医学-医学：研究与实验

CiteScore

6.70

自引率

2.60%

发文量

234

审稿时长

6-12 weeks

期刊介绍： Clinical and Translational Science (CTS), an official journal of the American Society for Clinical Pharmacology and Therapeutics, highlights original translational medicine research that helps bridge laboratory discoveries with the diagnosis and treatment of human disease. Translational medicine is a multi-faceted discipline with a focus on translational therapeutics. In a broad sense, translational medicine bridges across the discovery, development, regulation, and utilization spectrum. Research may appear as Full Articles, Brief Reports, Commentaries, Phase Forwards (clinical trials), Reviews, or Tutorials. CTS also includes invited didactic content that covers the connections between clinical pharmacology and translational medicine. Best-in-class methodologies and best practices are also welcomed as Tutorials. These additional features provide context for research articles and facilitate understanding for a wide array of individuals interested in clinical and translational science. CTS welcomes high quality, scientifically sound, original manuscripts focused on clinical pharmacology and translational science, including animal, in vitro, in silico, and clinical studies supporting the breadth of drug discovery, development, regulation and clinical use of both traditional drugs and innovative modalities.